Latest Articles
Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis - bmcwomenshealth.biomedcentral.com
Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis bmcwomenshealth.biomedcentral.com
Published: Feb. 28, 2025, 10:47 a.m.
Short-course, higher dose vaginal brachytherapy for endometrial cancer shown to be effective - MSN
Short-course, higher dose vaginal brachytherapy for endometrial cancer shown to be effective MSN
Published: Feb. 24, 2025, 4:36 a.m.
Dr Hinchcliff on the Benefits of Chemoimmunotherapy in Endometrial Cancer - OncLive
Dr Hinchcliff on the Benefits of Chemoimmunotherapy in Endometrial Cancer OncLive
Published: Feb. 21, 2025, 9:57 p.m.
Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer - Physician's Weekly
Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer Physician's Weekly
Published: Feb. 21, 2025, 6:31 a.m.
Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer - Diabetes In Control
Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer Diabetes In Control
Published: Feb. 20, 2025, 7:52 p.m.
Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer - HealthDay
Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer HealthDay
Published: Feb. 20, 2025, 4:55 p.m.
Short-course radiation therapy proves effective for treating endometrial cancer - @theU
Short-course radiation therapy proves effective for treating endometrial cancer @theU
Published: Feb. 19, 2025, 6:50 p.m.
Short-course radiation matches standard therapy for endometrial cancer - MSN
Short-course radiation matches standard therapy for endometrial cancer MSN
Published: Feb. 16, 2025, 9:30 a.m.
Dr Wagar on the Role of Adjuvant Immunotherapy in Endometrial Cancer - OncLive
Dr Wagar on the Role of Adjuvant Immunotherapy in Endometrial Cancer OncLive
Published: Feb. 13, 2025, 8:12 p.m.
Gesynta Pharma Receives $27 M For Endometriosis Novel Therapy Drug - Forbes
Gesynta Pharma Receives $27 M For Endometriosis Novel Therapy Drug Forbes
Published: Feb. 13, 2025, 5:04 p.m.
Link copied to clipboard!